<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7278986\results\search\disease\results.xml">
  <result pre="of Molecular Sciences1422-0067MDPI doi: 10.3390/ijms21103544ijms-21-03544 : Review The Role of" exact="Lipid Metabolism" post="in COVID-19 Virus Infection and as a Drug Target"/>
  <result pre="Molecular Sciences1422-0067MDPI doi: 10.3390/ijms21103544ijms-21-03544 : Review The Role of Lipid" exact="Metabolism" post="in COVID-19 Virus Infection and as a Drug Target"/>
  <result pre=": Review The Role of Lipid Metabolism in COVID-19 Virus" exact="Infection" post="and as a Drug Target https://orcid.org/0000-0001-8357-1252Abu-FarhaMohamed1â€ ThanarajThangavel Alphonse2â€ QaddoumiMohammad"/>
  <result pre="Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The current Coronavirus" exact="disease" post="2019 or COVID-19 pandemic has infected over two million"/>
  <result pre="thousand people at the time of writing this review. The" exact="disease" post="is caused by severe acute respiratory syndrome coronavirus 2"/>
  <result pre="of writing this review. The disease is caused by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though multiple vaccines"/>
  <result pre="writing this review. The disease is caused by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2). Even though multiple vaccines and"/>
  <result pre="this review. The disease is caused by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2). Even though multiple vaccines and treatments"/>
  <result pre="multiple vaccines and treatments are under development so far, the" exact="disease" post="is only slowing down under extreme social distancing measures"/>
  <result pre="as a central energy store. The role lipids play in" exact="viral infection" post="involves the fusion of the viral membrane to the"/>
  <result pre="a central energy store. The role lipids play in viral" exact="infection" post="involves the fusion of the viral membrane to the"/>
  <result pre="lipids play in viral infection involves the fusion of the" exact="viral" post="membrane to the host cell, viral replication, and viral"/>
  <result pre="the fusion of the viral membrane to the host cell," exact="viral" post="replication, and viral endocytosis and exocytosis. Since lipids play"/>
  <result pre="the viral membrane to the host cell, viral replication, and" exact="viral" post="endocytosis and exocytosis. Since lipids play a crucial function"/>
  <result pre="and exocytosis. Since lipids play a crucial function in the" exact="viral" post="life cycle, we asked whether drugs targeting lipid metabolism,"/>
  <result pre="this review, we discuss the role of lipid metabolism in" exact="viral infection" post="as well as the possibility of targeting lipid metabolism"/>
  <result pre="review, we discuss the role of lipid metabolism in viral" exact="infection" post="as well as the possibility of targeting lipid metabolism"/>
  <result pre="the possibility of targeting lipid metabolism to interfere with the" exact="viral" post="life cycle. coronavirus COVID-19 SARS-COV-2 lipid metabolism sphingolipid endocytosis"/>
  <result pre="Special Focus on the COVID-19 Virus The rapidly growing Coronavirus" exact="Disease" post="(COVID-19) pandemic represents a serious global challenge [1]. The"/>
  <result pre="highly pathogenic coronavirus into the human population after the severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) in 2002 and the Middle"/>
  <result pre="pathogenic coronavirus into the human population after the severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) in 2002 and the Middle East"/>
  <result pre="coronavirus into the human population after the severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) in 2002 and the Middle East respiratory"/>
  <result pre="respiratory syndrome coronavirus (SARS-CoV) in 2002 and the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) in 2012 [2,3]. Coronaviruses are a"/>
  <result pre="syndrome coronavirus (SARS-CoV) in 2002 and the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) in 2012 [2,3]. Coronaviruses are a family"/>
  <result pre="on various surfaces depend on several factors such as the" exact="viral" post="load, type of surface, suspension medium, humidity, temperature, and"/>
  <result pre="move on to other vital organs such as the lung." exact="Infections" post="with SARS-CoV-2 range from asymptomatic or mild infections restricted"/>
  <result pre="the lung. Infections with SARS-CoV-2 range from asymptomatic or mild" exact="infections" post="restricted to the upper respiratory tract to severe respiratory"/>
  <result pre="SARS-CoV-2 range from asymptomatic or mild infections restricted to the" exact="upper" post="respiratory tract to severe respiratory syndromes manifested by disseminated"/>
  <result pre="range from asymptomatic or mild infections restricted to the upper" exact="respiratory" post="tract to severe respiratory syndromes manifested by disseminated spread"/>
  <result pre="mild infections restricted to the upper respiratory tract to severe" exact="respiratory" post="syndromes manifested by disseminated spread to the lower airways"/>
  <result pre="to severe respiratory syndromes manifested by disseminated spread to the" exact="lower" post="airways leading to local inflammation and pneumonia, especially in"/>
  <result pre="especially in patients with comorbidities such as diabetes, hypertension, and" exact="cardiovascular disease" post="(CVD) [6]. People with diabetes mellitus (D.M.), severe obesity,"/>
  <result pre="in patients with comorbidities such as diabetes, hypertension, and cardiovascular" exact="disease" post="(CVD) [6]. People with diabetes mellitus (D.M.), severe obesity,"/>
  <result pre="as diabetes, hypertension, and cardiovascular disease (CVD) [6]. People with" exact="diabetes mellitus" post="(D.M.), severe obesity, and hypertension are more prone to"/>
  <result pre="(CVD) [6]. People with diabetes mellitus (D.M.), severe obesity, and" exact="hypertension" post="are more prone to be infected and are at"/>
  <result pre="complications and mortalities from COVID-19 [7]. The Chinese Centre for" exact="Disease" post="Control and Prevention reported increased mortality in individuals with"/>
  <result pre="Disease Control and Prevention reported increased mortality in individuals with" exact="diabetes" post="(2.3% for overall vs. 7.3% in patients with diabetes)"/>
  <result pre="in patients with diabetes) from 72,314 cases of COVID-19 [8]." exact="Severe obesity" post="and hypertension are present in 15.5% and 68.4% of"/>
  <result pre="patients with diabetes) from 72,314 cases of COVID-19 [8]. Severe" exact="obesity" post="and hypertension are present in 15.5% and 68.4% of"/>
  <result pre="diabetes) from 72,314 cases of COVID-19 [8]. Severe obesity and" exact="hypertension" post="are present in 15.5% and 68.4% of D.M. individuals,"/>
  <result pre="15.5% and 68.4% of D.M. individuals, respectively. While most severe" exact="infections" post="affect the elderly above 60 years, children on the"/>
  <result pre="order to deal with the high anabolic demands required during" exact="viral" post="replication [10,11,12,13]. Virion production requires a rearrangement of the"/>
  <result pre="the corresponding replication cycles. Lipids play a central role in" exact="viral infection," post="as they represent the structural foundations of cellular and"/>
  <result pre="infection, as they represent the structural foundations of cellular and" exact="viral" post="membranes [17]. Viruses attack lipid synthesis and signaling to"/>
  <result pre="involvement in membrane fusion, envelopment, and transformation are important for" exact="viral" post="replication, and molecules that impact lipids such as cholesterol"/>
  <result pre="as cholesterol and sphingolipids could be targeted to selectively impede" exact="viral" post="replication [17]. Viruses replicate within the host cell; hence,"/>
  <result pre="for entry and exit [17]. Lipids have several roles in" exact="viral" post="invasion, as they can act as direct and indirect"/>
  <result pre="viral invasion, as they can act as direct and indirect" exact="viral" post="receptors, fusion cofactors, and entry cofactors [18]. Currently, there"/>
  <result pre="trials [21,22,23,24,25,26,27,28]. While understanding the diverse roles of lipids in" exact="viral" post="replication has led to the discovery of lipid-active compounds"/>
  <result pre="for multiple therapies for COVID-19, and studies have shown that" exact="viral" post="entry, release, and consequently replication could possibly be blocked"/>
  <result pre="possibilities for antiviral therapies [17]. 2. Role of Lipids in" exact="Viral" post="Metabolism and Membrane Formation The host lipid biogenesis pathways"/>
  <result pre="for antiviral therapies [17]. 2. Role of Lipids in Viral" exact="Metabolism" post="and Membrane Formation The host lipid biogenesis pathways play"/>
  <result pre="an important role in the formation and function of the" exact="viral" post="replication complex, as well as the generation of the"/>
  <result pre="well as the generation of the energy required for efficient" exact="viral" post="replication [11,12,13]. Moreover, lipids can regulate the appropriate cellular"/>
  <result pre="[11,12,13]. Moreover, lipids can regulate the appropriate cellular distribution of" exact="viral" post="proteins, in addition to the assembly, trafficking, and release"/>
  <result pre="proteins, in addition to the assembly, trafficking, and release of" exact="viral" post="particles [31,32]. Coronaviruses firstly seize host cell intracellular membranes"/>
  <result pre="create new compartments known as double-membrane vesicles (DMVs) needed for" exact="viral" post="genome amplification. A specific phospholipid composition is required by"/>
  <result pre="for their replication [33]. DMVs are membranous structures that contain" exact="viral" post="proteins and an array of confiscated host factors, which"/>
  <result pre="ideal for coronavirus replication [34]. A recent study indicated that" exact="cytosolic" post="phospholipase A2Î± enzyme (cPLA2Î±), a crucial lipid processing enzyme"/>
  <result pre="critical for DMVsâ€™ formation and coronavirusesâ€™ replication [35]. Accumulation of" exact="viral" post="proteins and RNA, as well as creation of infectious"/>
  <result pre="of viral proteins and RNA, as well as creation of" exact="infectious" post="virus progeny, were significantly reduced in the presence of"/>
  <result pre="effects of specific lipids involved in lipid remodeling upon coronavirus" exact="infection" post="stay largely unexplored. Earlier reports have shown that most"/>
  <result pre="and dependence on both extracellular glucose and glutamine for optimal" exact="viral" post="replication [10]. This glucose uptake enhancement and phosphoinositide 3-kinase"/>
  <result pre="has not been described so far in the context of" exact="viral" post="infections. Lipogenesis and nucleotide synthesis were found to be"/>
  <result pre="in cells, and the glycolysis inhibitor 2-deoxy-d-glucose (2-DG) effectively repressed" exact="viral" post="replication and reversed the rhinoviruses-induced alterations of the host"/>
  <result pre="synthase (FASN) catalyzes the production of palmitic acid (C16:0) from" exact="cytosolic" post="acetyl-CoA and malonyl-CoA. The palmitic acid can then be"/>
  <result pre="storage in lipid droplets, or the palmitoylation of host and" exact="viral" post="proteins. As for sterol biosynthesis, two units of acetyl-CoA"/>
  <result pre="by catabolic beta-oxidation to yield high amounts of ATP [39,40,41]." exact="Cholesterol" post="and F.A. are essential for viral replication as they"/>
  <result pre="amounts of ATP [39,40,41]. Cholesterol and F.A. are essential for" exact="viral" post="replication as they constitute the main components of viral"/>
  <result pre="for viral replication as they constitute the main components of" exact="viral" post="membranes. Hence, the metabolism of these lipids has been"/>
  <result pre="process as it controls F.A. synthesis and can regulate the" exact="viral" post="replication. Some viruses can even harness this process by"/>
  <result pre="enhancing their activity [42]. As previously shown, the impact of" exact="viral infection" post="on various lipid species has been dramatic. Wu et"/>
  <result pre="their activity [42]. As previously shown, the impact of viral" exact="infection" post="on various lipid species has been dramatic. Wu et"/>
  <result pre="et al., recruited 25 SARS survivors 12 years after their" exact="infection" post="and compared them to healthy controls [43]. They demonstrated"/>
  <result pre="that SARS survivors were more susceptible to lung infections, tumors," exact="cardiovascular" post="disorders, and abnormal glucose metabolism compared to controls. More"/>
  <result pre="study, Nguyen et al. explored changes in the lipidome of" exact="primary" post="human epithelial cells infected with rhinoviruses [44]. Post-infection untargeted"/>
  <result pre="et al. explored changes in the lipidome of primary human" exact="epithelial" post="cells infected with rhinoviruses [44]. Post-infection untargeted lipidomics analysis"/>
  <result pre="pathways implicate multiple lipid modifying enzymes, which were increased upon" exact="infection" post="including lysocardiolipin acyltransferase (LCLAT), phosphoinositide phosphatase (PIP), and D.G."/>
  <result pre="have also looked at changes in the lipidome profile after" exact="infection" post="with viruses such as Enterovirus A71 and coxsackievirus and"/>
  <result pre="acid, docosahexaenoic acid, and eicosapentaenoic acid were consistently upregulated after" exact="infection" post="[45]. These data highlight the increase in lipid metabolism"/>
  <result pre="data highlight the increase in lipid metabolism that occurs after" exact="viral infection" post="where the virus highjacks and utilizes the host lipid"/>
  <result pre="highlight the increase in lipid metabolism that occurs after viral" exact="infection" post="where the virus highjacks and utilizes the host lipid"/>
  <result pre="utilizes the host lipid metabolism for their own propagation. 3." exact="Viral" post="Internalization: Lipid-Mediated Endocytosis Endocytosis is the process of internalization"/>
  <result pre="the internalization of various components into cells through membrane vesicles." exact="Viral" post="entry is dependent on the attachment and fusion of"/>
  <result pre="Viral entry is dependent on the attachment and fusion of" exact="viral" post="membrane with plasma membrane through an endocytosis-mediated process [46,47]."/>
  <result pre="ongoing COVID-19 pandemic is the role of lipid rafts in" exact="viral" post="entry into the host cells. Lipid rafts are sphingolipid-,"/>
  <result pre="and dynamin that are important for the endocytosis process and" exact="viral" post="entry. This process facilitates the fusion as well as"/>
  <result pre="facilitates the fusion as well as the release of the" exact="viral" post="genome into the host cell, where many enveloped viruses,"/>
  <result pre="low pH inside the endosomes to facilitate the fusion and" exact="viral" post="genome release [48]. SARS-CoV-2 belongs to the Betacoronavirus genus"/>
  <result pre="While S1 contains the receptor binding domain (RBD) required for" exact="viral" post="attachment to host cell receptors, S2 facilitates the fusion"/>
  <result pre="cell receptors, S2 facilitates the fusion of the cell and" exact="viral" post="membranes. The RBD of the S protein from SARS-CoV-2"/>
  <result pre="into target cells, as reported for MERS-CoV [54]. 4. Targeting" exact="Lipid Metabolism" post="Pathways The continuous emergence of new strains of coronaviruses"/>
  <result pre="target cells, as reported for MERS-CoV [54]. 4. Targeting Lipid" exact="Metabolism" post="Pathways The continuous emergence of new strains of coronaviruses"/>
  <result pre="the impact of such responses. Pathways that are fundamental to" exact="viral" post="attachment and fusion as well as pathways involved in"/>
  <result pre="attachment and fusion as well as pathways involved in the" exact="viral" post="replication and assembly are the foundations for drug discovery."/>
  <result pre="5. Targeting Lipid Synthesis Pathways One important pathway in the" exact="viral" post="replication is lipid metabolism that is hijacked by viruses"/>
  <result pre="by viruses and upregulated to meet the increased demand for" exact="viral" post="structural elements such as the viral cell membrane [42]."/>
  <result pre="the increased demand for viral structural elements such as the" exact="viral" post="cell membrane [42]. Cholesterol is an important component of"/>
  <result pre="viral structural elements such as the viral cell membrane [42]." exact="Cholesterol" post="is an important component of the viral cellular membrane."/>
  <result pre="cell membrane [42]. Cholesterol is an important component of the" exact="viral" post="cellular membrane. Statins reduce cholesterol synthesis by inhibiting the"/>
  <result pre="reduce cholesterol synthesis by inhibiting the activity of HMG-CoA reductase." exact="Multiple" post="studies have eluted to the role of statins in"/>
  <result pre="have eluted to the role of statins in treating different" exact="infections" post="[55]. Tleyjeh et al. have performed a meta-analysis to"/>
  <result pre="cohorts that looked at the role of statins in treating" exact="infections" post="like bacteremia, pneumonia, and sepsis [56]. In conclusion, they"/>
  <result pre="against all caused mortality within six months of diagnosis with" exact="pneumonia" post="with an adjusted hazard ratio of 0.67 (0.49 to"/>
  <result pre="the impact of using pravastatin on reducing the frequency of" exact="ventilator-associated pneumonia." post="Moreover, they studied if the treatment had favorable outcomes"/>
  <result pre="studied if the treatment had favorable outcomes in patients with" exact="Acute" post="Physiology and Chronic Health Evaluation II score (ICU severity"/>
  <result pre="treatment had favorable outcomes in patients with Acute Physiology and" exact="Chronic" post="Health Evaluation II score (ICU severity scoring classification) increasing"/>
  <result pre="(40 mg/day) and irbesartan (150 mg/day). Statinâ€™s beneficial impact on" exact="viral infection" post="could be due to its lipid lowering effects that"/>
  <result pre="mg/day) and irbesartan (150 mg/day). Statinâ€™s beneficial impact on viral" exact="infection" post="could be due to its lipid lowering effects that"/>
  <result pre="abilities disturb lipid rafts. Even though lipid-lowering capabilities might impact" exact="viral" post="replication, statins can also help in mitigating the impact"/>
  <result pre="replication, statins can also help in mitigating the impact of" exact="viral infection" post="through their immunomodulatory and anti-inflammatory properties [60]. This is"/>
  <result pre="statins can also help in mitigating the impact of viral" exact="infection" post="through their immunomodulatory and anti-inflammatory properties [60]. This is"/>
  <result pre="and anti-inflammatory properties [60]. This is particularly important since many" exact="cardiovascular" post="patients have been shown to have an elevated COVID-19"/>
  <result pre="cardiovascular patients have been shown to have an elevated COVID-19" exact="infection" post="risk [61]. Additionally, statins can also exert beneficial effects"/>
  <result pre="of the most severely infected people which are suffering from" exact="cardiovascular disease" post="and diabetes [55]. Targeting viruses with drugs can utilize"/>
  <result pre="the most severely infected people which are suffering from cardiovascular" exact="disease" post="and diabetes [55]. Targeting viruses with drugs can utilize"/>
  <result pre="severely infected people which are suffering from cardiovascular disease and" exact="diabetes" post="[55]. Targeting viruses with drugs can utilize the fact"/>
  <result pre="and mutations impacting their metabolism have been shown to cause" exact="disease" post="[65,66,67,68,69,70]. The sphingolipid biosynthesis pathway starts with the formation"/>
  <result pre="that sphingolipids play a vital protective role in lungs from" exact="pulmonary" post="leak and lung injury, and the modulation of their"/>
  <result pre="likely be exploited to counteract the associated complications of COVID-19" exact="infection" post="[76]. On this basis, the FDA-approved immunomodulator FTY720 (Fingolimod),"/>
  <result pre="trafficking, its downregulation causes relocation of the immune cells to" exact="secondary" post="lymphoid tissues, causing a reduction from the circulation and"/>
  <result pre="inflammatory cytokines, particularly IL-6, are thought to be associated with" exact="respiratory" post="failure in COVID-19 patients. However, it has been shown"/>
  <result pre="patients. However, it has been shown that the degree of" exact="lymphopenia" post="is not associated with risk of infection, and generally,"/>
  <result pre="lymphopenia is not associated with risk of infection, and generally," exact="infectious" post="complications were relatively low on S1P modulators [77,79]. It"/>
  <result pre="drugs do not suffer from an increased risk of community-acquired" exact="viral" post="infections [77,80]. We have recently shown that a higher"/>
  <result pre="do not suffer from an increased risk of community-acquired viral" exact="infections" post="[77,80]. We have recently shown that a higher level"/>
  <result pre="that a higher level of ANGPTL6 was associated with slow" exact="multiple sclerosis" post="progression and good response to fingolimod treatment [81]. Recently,"/>
  <result pre="great potential for clinical advancements in a broad range of" exact="autoimmune" post="and inflammatory diseases. In addition to the immunomodulatory property"/>
  <result pre="the management of this global pandemic crisis [82]. 7. Targeting" exact="Viral" post="Entry Pathway Inhibitors of virus cell entry and endocytosis"/>
  <result pre="well as inhibitors of certain cellular pathways involved in the" exact="viral" post="cycle constitute an important reservoir of antiviral drugs, such"/>
  <result pre="and reduce membrane cholesterol and destabilize the membrane structure, impact" exact="viral" post="infectivity significantly. Other direct inhibitors of the endocytosis process,"/>
  <result pre="possesss a very promising antiviral mechanism that can selectively impact" exact="viral" post="membranes but not host cellular membranes at very low"/>
  <result pre="the middle of the hydrophobic lipid bilayer, thus impacting the" exact="viral" post="membrane properties [89]. This drug is viral membrane-specific due"/>
  <result pre="thus impacting the viral membrane properties [89]. This drug is" exact="viral" post="membrane-specific due to the intrinsic mechanisms in host cellular"/>
  <result pre="protective against phospholipid hydroperoxides. While the effects of LJ0001 are" exact="limited" post="to in vitro activity, since it is a light"/>
  <result pre="were designed. These examples clearly highlight the importance of the" exact="viral" post="membrane as antiviral targets [89]. 8. Conclusion and Future"/>
  <result pre="Future Direction Lipid metabolism plays an important role in the" exact="viral infection" post="cycle. This role can be harnessed as anti-viral drugs"/>
  <result pre="Direction Lipid metabolism plays an important role in the viral" exact="infection" post="cycle. This role can be harnessed as anti-viral drugs"/>
  <result pre="that has shown promising beneficial effect in people with various" exact="viral" post="infections alongside their main role as a lipid lowering"/>
  <result pre="has shown promising beneficial effect in people with various viral" exact="infections" post="alongside their main role as a lipid lowering therapy."/>
  <result pre="species at the structure and signaling pathway level in the" exact="viral" post="life cycle. This will allow us to establish new"/>
  <result pre="of the manuscript. Funding This research was funded by Dasman" exact="diabetes" post="Institute. Conflicts of Interest The authors declare no conflict"/>
  <result pre="Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinCell202010.1016/j.cell.2020.02.05832155444 2.ZhouJ.ChuH.ChanJ.F.YuenK.Y.Middle East" exact="respiratory" post="syndrome coronavirus infection: Virus-host cell interactions and implications on"/>
  <result pre="and Antigenicity of the SARS-CoV-2 Spike GlycoproteinCell202010.1016/j.cell.2020.02.05832155444 2.ZhouJ.ChuH.ChanJ.F.YuenK.Y.Middle East respiratory" exact="syndrome" post="coronavirus infection: Virus-host cell interactions and implications on pathogenesisVirol."/>
  <result pre="Virus-host cell interactions and implications on pathogenesisVirol. J.20151221810.1186/s12985-015-0446-626690369 3.ChanJ.F.LauS.K.ToK.K.ChengV.C.WooP.C.YuenK.Y.Middle East" exact="respiratory" post="syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like diseaseClin. Microbiol."/>
  <result pre="cell interactions and implications on pathogenesisVirol. J.20151221810.1186/s12985-015-0446-626690369 3.ChanJ.F.LauS.K.ToK.K.ChengV.C.WooP.C.YuenK.Y.Middle East respiratory" exact="syndrome" post="coronavirus: Another zoonotic betacoronavirus causing SARS-like diseaseClin. Microbiol. Rev.20152846552210.1128/CMR.00102-1425810418"/>
  <result pre="Preparedness, decentralisation, and the hunt for patient zeroBMJ2020368bmj.m79910.1136/bmj.m79932111645 6.LiG.FanY.LaiY.HanT.LiZ.ZhouP.PanP.WangW.HuD.LiuX.et al.Coronavirus" exact="infections" post="and immune responsesJ. Med. Virol.20209242443210.1002/jmv.2568531981224 7.MuniyappaR.GubbiS.COVID-19 Pandemic, Corona Viruses,"/>
  <result pre="and immune responsesJ. Med. Virol.20209242443210.1002/jmv.2568531981224 7.MuniyappaR.GubbiS.COVID-19 Pandemic, Corona Viruses, and" exact="Diabetes" post="MellitusAm. J. Physiol. Endocrinol. Metab.202010.1152/ajpendo.00124.2020 8.WuZ.McGooganJ.M.Characteristics of and Important"/>
  <result pre="Endocrinol. Metab.202010.1152/ajpendo.00124.2020 8.WuZ.McGooganJ.M.Characteristics of and Important Lessons from the Coronavirus" exact="Disease" post="2019 (COVID-19) Outbreak in China: Summary of a Report"/>
  <result pre="a Report of 72314 Cases from the Chinese Center for" exact="Disease" post="Control and PreventionJAMA202010.1001/jama.2020.2648 9.LiuW.ZhangQ.ChenJ.XiangR.SongH.ShuS.ChenL.LiangL.ZhouJ.YouL.et al.Detection of Covid-19 in Children"/>
  <result pre="induces an anabolic reprogramming in host cell metabolism essential for" exact="viral" post="replicationProc. Natl. Acad. Sci. USA2018115E7158E716510.1073/pnas.180052511529987044 11.NagyP.D.StratingJ.R.van KuppeveldF.J.Building Viral Replication"/>
  <result pre="essential for viral replicationProc. Natl. Acad. Sci. USA2018115E7158E716510.1073/pnas.180052511529987044 11.NagyP.D.StratingJ.R.van KuppeveldF.J.Building" exact="Viral" post="Replication Organelles: Close Encounters of the Membrane TypesPLoS Pathog.201612e100591210.1371/journal.ppat.100591227788266"/>
  <result pre="for RNA replicationCell201014179981110.1016/j.cell.2010.03.05020510927 13.DiamondD.L.SyderA.J.JacobsJ.M.SorensenC.M.WaltersK.A.ProllS.C.McDermottJ.E.GritsenkoM.A.ZhangQ.ZhaoR.et al.Temporal proteome and lipidome profiles reveal" exact="hepatitis C" post="virus-associated reprogramming of hepatocellular metabolism and bioenergeticsPLoS Pathog.20106e100071910.1371/journal.ppat.100071920062526 14.ThaiM.ThakerS.K.FengJ.DuY.HuH.Ting"/>
  <result pre="Virol.201589103591037010.1128/JVI.01225-1526246569 19.DengS.Q.PengH.J.Characteristics of and Public Health Responses to the Coronavirus" exact="Disease" post="2019 Outbreak in ChinaJ. Clin. Med.2020957510.3390/jcm9020575 20.IrshadM.GuptaP.IrshadK.Molecular basis of"/>
  <result pre="Disease 2019 Outbreak in ChinaJ. Clin. Med.2020957510.3390/jcm9020575 20.IrshadM.GuptaP.IrshadK.Molecular basis of" exact="hepatocellular carcinoma" post="induced by hepatitis C virus infectionWorld J. Hepatol.201791305131410.4254/wjh.v9.i36.130529359013 21.LawtonG.Trials"/>
  <result pre="2019 Outbreak in ChinaJ. Clin. Med.2020957510.3390/jcm9020575 20.IrshadM.GuptaP.IrshadK.Molecular basis of hepatocellular" exact="carcinoma" post="induced by hepatitis C virus infectionWorld J. Hepatol.201791305131410.4254/wjh.v9.i36.130529359013 21.LawtonG.Trials"/>
  <result pre="ChinaJ. Clin. Med.2020957510.3390/jcm9020575 20.IrshadM.GuptaP.IrshadK.Molecular basis of hepatocellular carcinoma induced by" exact="hepatitis C" post="virus infectionWorld J. Hepatol.201791305131410.4254/wjh.v9.i36.130529359013 21.LawtonG.Trials of BCG vaccine will"/>
  <result pre="Virol.20189210.1128/JVI.01463-17 36.VijayR.HuaX.MeyerholzD.K.MikiY.YamamotoK.GelbM.MurakamiM.PerlmanS.Critical role of phospholipase A2 group IID in age-related" exact="susceptibility to" post="severe acute respiratory syndrome-CoV infectionJ. Exp. Med.20152121851186810.1084/jem.2015063226392224 37.HodsonL.GunnP.J.The regulation"/>
  <result pre="of phospholipase A2 group IID in age-related susceptibility to severe" exact="acute" post="respiratory syndrome-CoV infectionJ. Exp. Med.20152121851186810.1084/jem.2015063226392224 37.HodsonL.GunnP.J.The regulation of hepatic"/>
  <result pre="phospholipase A2 group IID in age-related susceptibility to severe acute" exact="respiratory" post="syndrome-CoV infectionJ. Exp. Med.20152121851186810.1084/jem.2015063226392224 37.HodsonL.GunnP.J.The regulation of hepatic fatty"/>
  <result pre="and its regulationAnnu. Rev. Biochem.19835253757910.1146/annurev.bi.52.070183.0025416137188 42.HeatonN.S.RandallG.Multifaceted roles for lipids in" exact="viral" post="infectionTrends Microbiol.20111936837510.1016/j.tim.2011.03.00721530270 43.WuQ.ZhouL.SunX.YanZ.HuC.WuJ.XuL.LiX.LiuH.YinP.et al.Altered Lipid Metabolism in Recovered SARS"/>
  <result pre="42.HeatonN.S.RandallG.Multifaceted roles for lipids in viral infectionTrends Microbiol.20111936837510.1016/j.tim.2011.03.00721530270 43.WuQ.ZhouL.SunX.YanZ.HuC.WuJ.XuL.LiX.LiuH.YinP.et al.Altered" exact="Lipid Metabolism" post="in Recovered SARS Patients Twelve Years after InfectionSci. Rep.20177911010.1038/s41598-017-09536-z28831119"/>
  <result pre="roles for lipids in viral infectionTrends Microbiol.20111936837510.1016/j.tim.2011.03.00721530270 43.WuQ.ZhouL.SunX.YanZ.HuC.WuJ.XuL.LiX.LiuH.YinP.et al.Altered Lipid" exact="Metabolism" post="in Recovered SARS Patients Twelve Years after InfectionSci. Rep.20177911010.1038/s41598-017-09536-z28831119"/>
  <result pre="entry: Open sesameCell200612472974010.1016/j.cell.2006.02.00716497584 47.MercerJ.HeleniusA.Virus entry by macropinocytosisNat. Cell Biol.20091151052010.1038/ncb0509-51019404330 48.MazzonM.MarshM.Targeting" exact="viral" post="entry as a strategy for broad-spectrum antiviralsF1000Res2019810.12688/f1000research.19694.1 49.GorbalenyaA.E.BakerS.C.BaricR.S.de GrootR.J.DrostenC.GulyaevaA.A.HaagmansB.L.LauberC.LeontovichA.M.NeumanB.W.et"/>
  <result pre="as a strategy for broad-spectrum antiviralsF1000Res2019810.12688/f1000research.19694.1 49.GorbalenyaA.E.BakerS.C.BaricR.S.de GrootR.J.DrostenC.GulyaevaA.A.HaagmansB.L.LauberC.LeontovichA.M.NeumanB.W.et al.The species" exact="Severe" post="acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it"/>
  <result pre="a strategy for broad-spectrum antiviralsF1000Res2019810.12688/f1000research.19694.1 49.GorbalenyaA.E.BakerS.C.BaricR.S.de GrootR.J.DrostenC.GulyaevaA.A.HaagmansB.L.LauberC.LeontovichA.M.NeumanB.W.et al.The species Severe" exact="acute" post="respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2Nat."/>
  <result pre="strategy for broad-spectrum antiviralsF1000Res2019810.12688/f1000research.19694.1 49.GorbalenyaA.E.BakerS.C.BaricR.S.de GrootR.J.DrostenC.GulyaevaA.A.HaagmansB.L.LauberC.LeontovichA.M.NeumanB.W.et al.The species Severe acute" exact="respiratory" post="syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2Nat. Microbiol.2020553654410.1038/s41564-020-0695-z32123347"/>
  <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting WuhanEmerg. Microbes Infections2020922123610.1080/22221751.2020.1719902 51.RajV.S.MouH.SmitsS.L.DekkersD.H.MullerM.A.DijkmanR.MuthD.DemmersJ.A.ZakiA.FouchierR.A.et al.Dipeptidyl peptidase 4"/>
  <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting WuhanEmerg. Microbes Infections2020922123610.1080/22221751.2020.1719902 51.RajV.S.MouH.SmitsS.L.DekkersD.H.MullerM.A.DijkmanR.MuthD.DemmersJ.A.ZakiA.FouchierR.A.et al.Dipeptidyl peptidase 4"/>
  <result pre="functional receptor for the SARS coronavirusNature200342645045410.1038/nature0214514647384 53.BraunE.SauterD.Furin-mediated protein processing in" exact="infectious diseases" post="and cancerClin. Transl. Immunol.20198e107310.1002/cti2.107331406574 54.HoffmannM.Kleine-WeberH.SchroederS.KrugerN.HerrlerT.ErichsenS.SchiergensT.S.HerrlerG.WuN.H.NitscheA.et al.SARS-CoV-2 Cell Entry Depends"/>
  <result pre="review and meta-analysisArch. Intern. Med.20091691658166710.1001/archinternmed.2009.28619822822 57.DouglasI.EvansS.SmeethL.Effect of statin treatment on" exact="short" post="term mortality after pneumonia episode: Cohort studyBMJ2011342d164210.1136/bmj.d164221471172 58.MakrisD.ManoulakasE.KomnosA.PapakrivouE.TzovarasN.HovasA.ZintzarasE.ZakynthinosE.Effect of"/>
  <result pre="Med.20091691658166710.1001/archinternmed.2009.28619822822 57.DouglasI.EvansS.SmeethL.Effect of statin treatment on short term mortality after" exact="pneumonia" post="episode: Cohort studyBMJ2011342d164210.1136/bmj.d164221471172 58.MakrisD.ManoulakasE.KomnosA.PapakrivouE.TzovarasN.HovasA.ZintzarasE.ZakynthinosE.Effect of pravastatin on the frequency"/>
  <result pre="episode: Cohort studyBMJ2011342d164210.1136/bmj.d164221471172 58.MakrisD.ManoulakasE.KomnosA.PapakrivouE.TzovarasN.HovasA.ZintzarasE.ZakynthinosE.Effect of pravastatin on the frequency of" exact="ventilator-associated pneumonia" post="and on intensive care unit mortality: Open-label, randomized studyCrit."/>
  <result pre="Cohort studyBMJ2011342d164210.1136/bmj.d164221471172 58.MakrisD.ManoulakasE.KomnosA.PapakrivouE.TzovarasN.HovasA.ZintzarasE.ZakynthinosE.Effect of pravastatin on the frequency of ventilator-associated" exact="pneumonia" post="and on intensive care unit mortality: Open-label, randomized studyCrit."/>
  <result pre="statinsImmunology2018154697510.1111/imm.1290229392731 61.GuoT.FanY.ChenM.WuX.ZhangL.HeT.WangH.WanJ.WangX.LuZ.Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus" exact="Disease" post="2019 (COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.101732219356 62.MadjidM.Safavi-NaeiniP.SolomonS.D.VardenyO.Potential Effects of Coronaviruses on the"/>
  <result pre="Coronaviruses on the Cardiovascular System: A ReviewJAMA Cardiol.202010.1001/jamacardio.2020.1286 63.AllevaL.M.BuddA.C.ClarkI.A.Minimising Influenza" exact="Disease" post="with FibratesInt. J. Infect. Dis.200812e17610.1016/j.ijid.2008.05.440 64.YuanS.ChuH.ChanJ.F.YeZ.W.WenL.YanB.LaiP.M.TeeK.M.HuangJ.ChenD.et al.SREBP-dependent lipidomic reprogramming"/>
  <result pre="fibrosisMatrix Biol.201868-6923024710.1016/j.matbio.2018.01.00629343457 66.SchwalmS.PfeilschifterJ.HuwilerA.Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat" exact="chronic" post="inflammatory kidney diseasesBasic Clin. Pharmacol. Toxicol.2014114444910.1111/bcpt.1210323789924 67.HuwilerA.KolterT.PfeilschifterJ.SandhoffK.Physiology and pathophysiology"/>
  <result pre="of ceramide to sphingosine 1-phosphate as a novel strategy for" exact="cancer" post="therapyCrit Rev Oncol. Hematol.20076315015910.1016/j.critrevonc.2007.04.01017560117 70.HuwilerA.PfeilschifterJ.Altering the sphingosine-1-phosphate/ceramide balance: A"/>
  <result pre="Oncol. Hematol.20076315015910.1016/j.critrevonc.2007.04.01017560117 70.HuwilerA.PfeilschifterJ.Altering the sphingosine-1-phosphate/ceramide balance: A promising approach for" exact="tumor" post="therapyCurr. Pharm. Des.2006124625463510.2174/13816120677901042217168766 71.UlrichS.HuwilerA.LoitschS.SchmidtH.SteinJ.M.De novo ceramide biosynthesis is associated"/>
  <result pre="receptor signaling pathways as a promising approach for treatment of" exact="autoimmune" post="and inflammatory diseasesPharmacol. Res.202015410417010.1016/j.phrs.2019.02.00930776422 79.LunaG.AlpingP.BurmanJ.FinkK.Fogdell-HahnA.GunnarssonM.HillertJ.Langer-GouldA.LyckeJ.NilssonP.et al.Infection Risks Among Patients"/>
  <result pre="and inflammatory diseasesPharmacol. Res.202015410417010.1016/j.phrs.2019.02.00930776422 79.LunaG.AlpingP.BurmanJ.FinkK.Fogdell-HahnA.GunnarssonM.HillertJ.Langer-GouldA.LyckeJ.NilssonP.et al.Infection Risks Among Patients with" exact="Multiple" post="Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable TherapiesJAMA"/>
  <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 86.BlaisingJ.LevyP.L.PolyakS.J.StaniferM.BoulantS.PecheurE.I.Arbidol"/>
  <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 86.BlaisingJ.LevyP.L.PolyakS.J.StaniferM.BoulantS.PecheurE.I.Arbidol inhibits"/>
  <result pre="syndrome coronavirus replication in cell cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 86.BlaisingJ.LevyP.L.PolyakS.J.StaniferM.BoulantS.PecheurE.I.Arbidol inhibits" exact="viral" post="entry by interfering with clathrin-dependent traffickingAntiv. Res.201310021521910.1016/j.antiviral.2013.08.008 87.WojcechowskyjJ.A.DomsR.W.A Potent,"/>
  <result pre="clathrin-dependent traffickingAntiv. Res.201310021521910.1016/j.antiviral.2013.08.008 87.WojcechowskyjJ.A.DomsR.W.A Potent, Broad-Spectrum Antiviral Agent that Targets" exact="Viral" post="MembranesViruses201021106110910.3390/v205110621994673 88.WolfM.C.FreibergA.N.ZhangT.Akyol-AtamanZ.GrockA.HongP.W.LiJ.WatsonN.F.FangA.Q.AguilarH.C.et al.A broad-spectrum antiviral targeting entry of enveloped"/>
  <result pre="drugs that can used as broad-spectrum antiviral drugs to inhibit" exact="viral" post="entry, membrane fusion, or endocytosis as well as inhibition"/>
 </snippets>
</snippetsTree>
